Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
61.02
-1.06 (-1.71%)
Dec 20, 2024, 4:00 PM EST - Market closed
Utah Medical Products Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 44.08 | 50.22 | 52.28 | 49.05 | 42.18 | 46.9 | Upgrade
|
| Revenue Growth (YoY) | -14.35% | -3.93% | 6.58% | 16.30% | -10.08% | 11.68% | Upgrade
|
| Cost of Revenue | 18.16 | 20.19 | 20.09 | 18.14 | 16.63 | 17.44 | Upgrade
|
| Gross Profit | 25.92 | 30.04 | 32.2 | 30.92 | 25.55 | 29.47 | Upgrade
|
| Selling, General & Admin | 8.01 | 11.04 | 11.24 | 11.51 | 11.35 | 11.34 | Upgrade
|
| Research & Development | 0.84 | 0.56 | 0.49 | 0.53 | 0.49 | 0.48 | Upgrade
|
| Operating Expenses | 8.85 | 11.6 | 11.74 | 12.04 | 11.84 | 11.82 | Upgrade
|
| Operating Income | 17.07 | 18.44 | 20.46 | 18.88 | 13.71 | 17.65 | Upgrade
|
| Interest & Investment Income | 3.62 | 3.04 | 0.66 | 0.17 | 0.11 | 0.25 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | -0.01 | -0.02 | - | - | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.03 | 0.28 | 0.23 | 0.02 | 0.02 | 0.09 | Upgrade
|
| EBT Excluding Unusual Items | 20.67 | 21.75 | 21.33 | 19.06 | 13.84 | 17.92 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.02 | Upgrade
|
| Legal Settlements | -2.46 | -1.66 | -0.67 | - | - | -0.02 | Upgrade
|
| Pretax Income | 18.21 | 20.09 | 20.66 | 19.06 | 13.84 | 17.88 | Upgrade
|
| Income Tax Expense | 2.95 | 3.45 | 4.19 | 4.27 | 3.04 | 3.16 | Upgrade
|
| Net Income | 15.26 | 16.64 | 16.47 | 14.79 | 10.8 | 14.73 | Upgrade
|
| Net Income to Common | 15.26 | 16.64 | 16.47 | 14.79 | 10.8 | 14.73 | Upgrade
|
| Net Income Growth | -9.74% | 0.98% | 11.39% | 36.95% | -26.68% | -20.63% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | -1.90% | -0.17% | -0.46% | -0.33% | -1.79% | -0.24% | Upgrade
|
| EPS (Basic) | 4.28 | 4.58 | 4.53 | 4.05 | 2.95 | 3.96 | Upgrade
|
| EPS (Diluted) | 4.28 | 4.57 | 4.52 | 4.04 | 2.94 | 3.94 | Upgrade
|
| EPS Growth | -7.97% | 1.15% | 11.93% | 37.41% | -25.36% | -20.42% | Upgrade
|
| Free Cash Flow | 16.92 | 21.64 | 20.34 | 20.65 | 19.28 | 16.52 | Upgrade
|
| Free Cash Flow Per Share | 4.74 | 5.95 | 5.58 | 5.64 | 5.25 | 4.42 | Upgrade
|
| Dividend Per Share | 1.200 | 1.185 | 1.165 | 0.855 | 1.120 | 1.100 | Upgrade
|
| Dividend Growth | 1.69% | 1.72% | 36.26% | -23.66% | 1.82% | 1.38% | Upgrade
|
| Gross Margin | 58.80% | 59.81% | 61.58% | 63.03% | 60.57% | 62.82% | Upgrade
|
| Operating Margin | 38.73% | 36.71% | 39.13% | 38.49% | 32.50% | 37.63% | Upgrade
|
| Profit Margin | 34.62% | 33.12% | 31.51% | 30.15% | 25.60% | 31.40% | Upgrade
|
| Free Cash Flow Margin | 38.38% | 43.09% | 38.90% | 42.10% | 45.70% | 35.21% | Upgrade
|
| EBITDA | 20.17 | 24.75 | 27.49 | 26.16 | 20.88 | 24.49 | Upgrade
|
| EBITDA Margin | 45.77% | 49.28% | 52.58% | 53.33% | 49.50% | 52.22% | Upgrade
|
| D&A For EBITDA | 3.1 | 6.32 | 7.03 | 7.28 | 7.17 | 6.84 | Upgrade
|
| EBIT | 17.07 | 18.44 | 20.46 | 18.88 | 13.71 | 17.65 | Upgrade
|
| EBIT Margin | 38.73% | 36.71% | 39.13% | 38.49% | 32.50% | 37.63% | Upgrade
|
| Effective Tax Rate | 16.19% | 17.19% | 20.26% | 22.42% | 21.98% | 17.65% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.